Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal CancerEmmanouil Fokas, Katica Krajinovic, Anke Schlenska‐Lange et al.|JAMA Oncology|2021Cited by 349
Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104—A Randomized Trial of the German AIO CRC Study GroupNicolas Moosmann, Volker Heinemann, Daniel Oruzio et al.|Journal of Clinical Oncology|2011Cited by 117
Prognostic value of cetuximab‐related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: Results from a randomized trial of the GERMAN AIO CRC Study GroupSebastian Stintzing, Volker Heinemann, Christine Kapaun et al.|International Journal of Cancer|2012Cited by 81